Healthstream Inc insider trading
Every open-market purchase and sale by Healthstream Inc's officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following Healthstream Inc’s insiders pay?
From August 16, 2010 to September 15, 2026, 19 insiders reported 2 open-market purchases and 82 sales not made under a pre-set plan in Healthstream Inc. Twelve months after each purchase was reported, the shares were −8.6% against the S&P 500 on average (median −8.6%), over 2 purchases with a full year of prices; 50% beat the index. After sales, the shares moved −8.3% against the index over 12 months (a negative figure means selling was the right call). That rests on fewer than 20 purchases, too few to read much into. Buying each purchase the day after it was reported, an equal amount each, held 12 months or until that insider reported a sale, would have turned $10,000 on May 5, 2021 into $11,685 by November 2, 2026, +2.9% a year. It held shares 28% of the time; the S&P 500 on those same days, with Treasury bills otherwise, made $11,794 (+3.1% a year), and held throughout $19,580 (+13.1%).
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Mclaren Jeffrey L | Director | 0 | — | — | 12 | +2.3% (12) | August 2, 2022 |
| Sousa Michael | Executive Vice President | 0 | — | — | 10 | −9.3% (10) | February 26, 2024 |
| Taylor Tate Deborah | Director | 0 | — | — | 9 | −13.7% (8) | December 1, 2025 |
| Newman Arthur E | Executive Vice President | 0 | — | — | 8 | −16.2% (8) | August 14, 2013 |
| Harris C Martin | Director | 0 | — | — | 6 | −11.9% (6) | May 16, 2019 |
| Hayden Gerard M Jr | Chief Financial Officer | 0 | — | — | 6 | −4.7% (6) | May 17, 2018 |
| Doster Jeffrey | Chief Information Officer | 0 | — | — | 5 | −6.0% (5) | February 26, 2018 |
| Rebrovick Linda | Director | 0 | — | — | 5 | −1.8% (5) | May 15, 2019 |
| Fenstermacher Scott | Senior Vice President | 0 | — | — | 4 | −13.7% (4) | February 28, 2025 |
| O'hara Kevin P | Executive Vice President | 0 | — | — | 4 | −21.7% (2) | May 20, 2026 |
| Stead William | Director | 0 | — | — | 3 | +4.8% (3) | February 26, 2018 |
| Frist Robert A Jr | CEO and Chairman | 1 | −29.5% (1) | 0% | 1 | — | September 15, 2026 |
| Gordon Frank | Director | 1 | +12.4% (1) | 100% | 1 | −12.5% (1) | November 19, 2021 |
| Pearson J Edward | President and COO | 0 | — | — | 2 | +4.9% (2) | April 28, 2023 |
| Polley Dale W | Director | 0 | — | — | 2 | −25.3% (2) | August 14, 2014 |
| Coady Trisha L | Senior Vice President | 0 | — | — | 1 | +3.8% (1) | February 22, 2024 |
| Cunningham Jeff | Chief Technology Officer | 0 | — | — | 1 | — | December 10, 2025 |
| Dent Thompson | Director | 0 | — | — | 1 | −21.6% (1) | March 13, 2015 |
| Shmerling Michael D | Director | 0 | — | — | 1 | −36.6% (1) | August 15, 2013 |
When several insiders traded Healthstream Inc
Months when 2 or more insiders became net buyers, or 3 or more net sellers, of Healthstream Inc in reports dated in the 91 days before the month end, and how the stock did against the S&P 500 from that month end. After 8 selling crowds, +16.5%. One company's history is too short to judge by; the test across every company is the better guide.
| Month | Crowd | 3 months on, vs S&P 500 | 6 months | 12 months |
|---|---|---|---|---|
| December 31, 2025 | 3 selling | −7.7% | +15.6% | not yet |
| August 30, 2024 | 3 selling | +6.9% | +10.4% | −19.1% |
| April 30, 2024 | 3 selling | +5.3% | −2.6% | +18.4% |
| February 28, 2018 | 3 selling | +20.7% | +26.3% | +15.2% |
| March 31, 2016 | 3 selling | +18.9% | +14.7% | −9.2% |
| August 29, 2014 | 7 selling | +6.6% | −6.8% | −4.7% |
| March 28, 2013 | 7 selling | +7.5% | +54.9% | −5.3% |
| November 30, 2011 | 5 selling | +11.1% | +19.6% | +25.4% |